ERIN DEHAVEN: Open Payments
NPI 1518075852 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 38 payments from 20 companies in 2025. Trend: 2023 $167 · 2024 $473 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $225 |
| Novo Nordisk Inc | 8 | $136 |
| Neuronetics, Inc. | 1 | $56 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| Exact Sciences Corporation | 2 | $42 |
| PFIZER INC. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Lilly USA, LLC | 2 | $35 |
| Amgen Inc. | 2 | $30 |
| Insulet Corporation | 1 | $28 |
Products named: BREZTRI, Ozempic, NEUROSTAR TMS THERAPY SYSTEM, VOQUEZNA, ELIQUIS, Rybelsus, JARDIANCE, FARXIGA.
Industry payments across ID — which companies pay providers there.
